Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14270348 | 0.87 | LMNA (0.46) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL12112873 | 0.86 | MAPT (0.58) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL10078862 | 0.84 | NPC1 (0.43) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL19752299 | 0.84 | NPC1 (0.43) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL27551428 | 0.83 | KDM4E (0.47) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL6252241 | 0.81 | PLAU (0.55) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL17299585 | 0.81 | IDO1 (0.54) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL3142955 | 0.81 | ALDH1A1 (0.65) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL4438439 | 0.81 | KDM4E (0.41) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL20809426 | 0.81 | KDM4E (0.41) | RAB9AKDM4ENPC1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3719099-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| EP-3327100-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10600975-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-23 | — | — | US | disclosed |
| US-10230060-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-12 | — | — | US | disclosed |
| EP-3327100-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-9911930-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-8431243-B2 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431243-B2 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-30 | — | — | US | disclosed |
| EP-2489716-A2 | Phosphorescent materials | Universal Display Corporation (US) | 2012-08-22 | — | — | EP | disclosed |
| EP-2465912-A1 | Phosphorescent Materials | Universal Display Corporation (US) | 2012-06-20 | — | — | EP | disclosed |
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2008109824-A2 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2008-09-12 | — | — | WO | disclosed |
| CN-100375749-C | Luminescence device and display apparatus | CANON KK (JP) | 2008-03-19 | — | — | CN | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | PCID2, ICMT, ORAI2 | RAB9A 1685/4885KDM4E 2381/4885NPC1 3616/4885 |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RUVBL2, TERT, OR10J3 | RAB9A 1698/4885KDM4E 3403/4885NPC1 4327/4885 |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, ICMT | RAB9A 2283/4885KDM4E 3053/4885NPC1 3961/4885 |
| US-10230060-B2 | Organic electroluminescent materials and devices | RUVBL2, OR10J3, EML4 | RAB9A 2028/4885KDM4E 3060/4885NPC1 4152/4885 |
| US-10600975-B2 | Organic electroluminescent materials and devices | TERT, OR10J3, RUVBL2 | RAB9A 1716/4885KDM4E 3344/4885NPC1 4327/4885 |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, PORCN | RAB9A 2720/4885KDM4E 3726/4885NPC1 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.